Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004924208 | SCV005593884 | uncertain significance | not specified | 2024-09-30 | criteria provided, single submitter | clinical testing | The p.V386I variant (also known as c.1156G>A), located in coding exon 6 of the GALNT12 gene, results from a G to A substitution at nucleotide position 1156. The valine at codon 386 is replaced by isoleucine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, the in silico prediction for this alteration is inconclusive. Based on the available evidence, the clinical significance of this variant remains unclear. |